Indonesia Urges Greater Transparency in Cross-Border Copyright Royalty Governance Before 35 Countries 
SaunaKits.com Opens Its Upstate South Carolina Showroom, Bringing Hands-On Sauna Shopping to the Southeast 
Encore Construction Shares Guidance to Help Homeowners Avoid Costly Water Damage Insurance Claim Mistakes Osmotica to Present at 10th Annual SVB Leerink Global Healthcare Conference
BRIDGEWATER, N.J., Feb. 18, 2021 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or…
MacroGenics Announces Date of Fourth Quarter and Full Year 2020 Financial Results Conference Call
ROCKVILLE, MD, Feb. 18, 2021 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical…
Technology and Health Leaders Join Myriad Genetics, Advance in Senior Roles to Drive Key Enterprise Functions, Transformation and Growth Initiatives
New talent and promotions span core businesses, transformation, IT, revenue cycle management, business development, marketing,…
Apellis Pharmaceuticals to Hold Fourth Quarter and Full Year 2020 Earnings Conference Call on February 25, 2021
WALTHAM, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical…
Codexis to Present at Upcoming Virtual Healthcare Conferences
REDWOOD CITY, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading enzyme…
Ascendis Pharma A/S Announces Participation at SVB Leerink 10th Annual Global Healthcare Conference
COPENHAGEN, Denmark, Feb. 18, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical…
Caladrius Biosciences to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Thursday, February 25, 2021 at 4:30 p.m. Eastern Time
BASKING RIDGE, N.J., Feb. 18, 2021 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius”…
Diffusion Pharmaceuticals Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares of Common Stock
CHARLOTTESVILLE, Va., Feb. 18, 2021 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the…
Trevi Therapeutics to Present at 10th Annual SVB Leerink Global Healthcare Conference
NEW HAVEN, Conn., Feb. 18, 2021 (GLOBE NEWSWIRE) — Trevi Therapeutics, Inc. (Nasdaq: TRVI), a…
Novavax Announces Memorandum of Understanding with Gavi for Cumulative Supply to COVAX Facility of 1.1 Billion Doses of COVID-19 Vaccine
Advances joint commitment from Novavax, Serum Institute of India and Gavi to ensure equitable access…
Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2020 Results and Corporate Update
CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome…
Larimar Therapeutics to Present at the SVB Leerink 10th Annual Global Healthcare Conference
BALA CYNWYD, Pa., Feb. 18, 2021 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR),…
Cambium Networks Reports Fourth Quarter and Full Year 2020 Financial Results
Record revenues of $82.8 million, increased 13% sequentially, up 29% year-over-year Gross margin of 51.0%,…
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2020 Financial Results After the Close of Markets on Thursday, March 11, 2021
LAKE FOREST, Ill., Feb. 18, 2021 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the…
Cara Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
STAMFORD, Conn., Feb. 18, 2021 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company…
Paratek Pharmaceuticals to Present at the 10th Annual SVB Leerink Global Healthcare Conference
BOSTON, Feb. 18, 2021 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical…
Voyager Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Participate in Upcoming Investor Conference
CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage…
Oyster Point Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
OC-01 (Varenicline) Nasal Spray New Drug Application (NDA) Submitted to the U.S. Food and Drug…
Bio-Path Holdings, Inc. Announces Closing of $13.0 Million Public Offering of Common Stock
HOUSTON, Feb. 18, 2021 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (Nasdaq:BPTH), a biotechnology company leveraging…
Pipeline and capital for growth
Key 2020 events: Jyseleca approved for rheumatoid arthritis (RA) in Europe & Japan Gilead decided…